N Ouimet, C C Chan, S Charleson, D Claveau, R Gordon, D Guay, C S Li, M Ouellet, D M Percival, D Riendeau, E Wong, R Zamboni, P Prasit
Merck Frosst Centre for Therapeutic Research, Merck Frosst Canada Inc., Pointe Claire-Dorval, Québec, Canada.
Bioorganic & medicinal chemistry letters 1999 Jan 18Substituted heterocyclic analogs in the Flosulide class were investigated as potential selective cyclooxygenase-2 inhibitors. 6-(4-Ethyl-2-thiazolylthio)-5-methanesulfonamido-3H-isobe nzofuran-1-one 14 was found to be the optimal compound in the series with superior in vitro and in vivo activities.
N Ouimet, C C Chan, S Charleson, D Claveau, R Gordon, D Guay, C S Li, M Ouellet, D M Percival, D Riendeau, E Wong, R Zamboni, P Prasit. Substituted heterocyclic analogs as selective COX-2 inhibitors in the flosulide class. Bioorganic & medicinal chemistry letters. 1999 Jan 18;9(2):151-6
PMID: 10021918
View Full Text